SNGXEarnings•prnewswire•
Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results
Sentiment:Neutral (60)
Summary
PRINCETON, N.J., Aug. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 14, 2025 by prnewswire